Neuroscience
Welcome to our Neuroscience Section
At Janssen we strive for excellence and, as a partner in neuroscience, we are committed to delivering high quality medical education whilst providing a platform for knowledge exchange and innovation. To help us achieve this we are privileged to have the support and participation of the internationally renowned experts who form our scientific committee and faculties. Their involvement ensures we continue to provide clinically relevant and balanced education.
Janssen Medical Education Academy
is your central resource for accessing up-to-date Medical Education materials in Major Depressive Disorder (MDD). By clicking below, you will be directed to content shared by experts within their field. New content will be added on a regular basis.
is your central resource for the latest Medical Education materials in Multiple Sclerosis (MS). Grow your knowledge in this rapidly evolving disease area by clicking below to access the latest learning resources, including on-demand podcasts, webinars and interactive patient case studies. Up-to-date content shared by leading experts in this field will be added on a regular basis.
is your central resource for accessing up-to-date Medical Education materials in schizophrenia. By clicking below, you will be directed to content shared by experts within their field. New content will be added on a regular basis.
The NSME-forum is an innovative programme developed with an eminent scientific committee where, through live interactive broadcasts, viewing clinicians can hear experts discuss latest data and its impact on clinical practice. During each roundtable broadcast you will have the opportunity to ask questions of the faculty which will be addressed live.
Once registered for an upcoming broadcast you may also choose to watch the webinar at a more convenient time along with other past broadcasts.
Disease Awareness
Major depressive disorder (MDD) can be a devastating condition for patients and their families alike, casting a shadow across their lives. Here at our MDD hub, we explore what more can be done to help these patients achieve remission and relief, so they can step out of the shadow of MDD.
Multiple sclerosis is a chronic, inflammatory, demyelinating and degenerative disorder that affects approximately 2.8 million people worldwide. Use our MS pages to discover more about MS, the associated symptoms (both ‘visible’ and invisible’) and the importance of talking to your patients living with MS to gain a clearer insight into how their condition is affecting them.
Major Depressive Disorder Partnerships
The French Association of Biological Psychiatry (AFPBN) was founded in 1979 by Professor Pierre Deniker with the aim of promoting the scientific study of psychiatric conditions, their prevention and their treatment.
AFPBN now has nearly 450 active members, who are involved in a wide variety of approaches: clinical psychiatry, neuropsychology, epidemiology, neuroimaging, genetics, molecular biology, psychopharmacology, neurophysiology.
The International College of Neuropsychopharmacology (CINP) (Collegium Internationale Neuro-Psychopharmacologicum) is a truly worldwide organization established over 60 years ago in Zurich, Switzerland and can count on a widespread support from all over the world by its active members. Holding regular meetings in form of Training, Educational Programs, International Meetings and World Congresses, CINP reaches interested researchers all over the world. Clinicians hear about the latest research advances and new treatments whilst researchers hear about new clinical needs and problems. Therefore, CINP is dedicated to promoting research and education on a worldwide basis.
With active individual members in as many as 88 countries and 44 National Psychiatric Association Members who represent more than 80,000 European psychiatrists, the European Psychiatric Association (EPA) is the main association representing psychiatry in Europe. The EPA’s activities address the interests of psychiatrists in academia, research and practice throughout all stages of career development. The EPA deals with psychiatry and its related disciplines and focuses on the improvement of care for the mentally ill as well as on the development of professional excellence.
Medscape, the leading online provider of Continuing Medical Education (CME) and relevant educational portfolio spanning the whole spectrum of the healthcare world. Janssen continues to provide support to Medscape CME programmes in major depressive disorder.
The World Federation of Societies of Biological Psychiatry is a non-profit, international organization composed of over 60 national societies of biological psychiatry, representing over 4,500 professionals. As a world authority on biological psychiatry, WFSBP is also highly committed to pioneering and promoting the highest levels of education and dissemination within the field.
Multiple Sclerosis Partnerships
Transformative education from EXCEMED puts expertise into practice by engaging thousands of healthcare professionals around the globe and measuring their improvements in clinical performance. EXCEMED opens a world of opportunity through blended learning journeys whose destination is improved patient outcomes. EXCEMED’s core mission is to help physicians, scientists and nurses achieve optimal outcomes for patients. Each of the programmes is an educational journey with face-to-face and digital components. The result is an interactive, multi-disciplinary and dynamic learning experience. The EXCEMED name symbolizes a drive for excellence and reflects a passion for delivering the absolute best in CME/CPD.
Medscape, the leading online provider of Continuing Medical Education (CME) and relevant educational portfolio spanning the whole spectrum of the healthcare world. Janssen continues to provide support to Medscape CME programmes in multiple sclerosis.
Founded 12 years ago, SEI Healthcare is a global professional Independent Medical Education organization. Our mission is to organise the world’s medical information and make it universally accessible & useful.
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is a non-profit organisation and an independent representative European-wide organisation devoted to MS. The ECTRIMS mission is to facilitate communication, create synergies, and promote and enhance research and learning among professionals for the ultimate benefit of people affected by MS. ECTRIMS works with researchers and clinicians of its member countries and with other organisations that share similar missions and objectives on a worldwide scale, creating networking and collaboration opportunities. The ultimate goal of ECTRIMS is to improve basic and clinical research and clinical outcomes in MS.
Schizophrenia Partnerships
With active individual members in as many as 88 countries and 44 National Psychiatric Association Members who represent more than 80,000 European psychiatrists, the European Psychiatric Association (EPA) is the main association representing psychiatry in Europe. The EPA’s activities address the interests of psychiatrists in academia, research and practice throughout all stages of career development. The EPA deals with psychiatry and its related disciplines and focuses on the improvement of care for the mentally ill as well as on the development of professional excellence.
Medscape, the leading online provider of Continuing Medical Education (CME) and relevant educational portfolio spanning the whole spectrum of the healthcare world. Janssen continues to provide support to Medscape CME programmes in schizophrenia.
